Publications Pre-2010

All publications in peer-reviewed journals.  

Publications before Colorado State University:

1. “cis and trans-Azoalkanes: Force field determination of molecular structures, heats of formation and strain energies,” Debbie C. Crans and James P. Snyder, Chem. Ber., 1980, 113, 1201-1204.

2. “A theoretical evaluation of the synergetic capto-dative stabilization of free radicals,” Debbie C. Crans, Timothy Clark and Paul von R. Schleyer, Tetrahedron Letters, 1980, 21, 3681-3684.

3. “Tetracoordinate planar carbon: A singlet biradical,” Debbie C. Crans and James P. Snyder, J. Am. Chem. Soc J. Am. Chem. Soc., 1980, 102, 7152-7154.

4. “A convenient synthesis of disodium acetyl phosphate for use in in situ ATP cofactor regeneration,” Debbie C. Crans and George M. Whitesides, J. Org. Chem., 1983, 48, 3130-3132.

5. “Practical enzymatic synthesis of adenosine-5′-0-(3-thiotriphosphate) (ATP-g-S,)” Obsidiana Abril, Debbie C. Crans and George M. Whitesides, J. Org. Chem., 1984, 49, 1360-1364.

6. “Glycerol kinase: Substrate specificity,” Debbie C. Crans and George M. Whitesides, J. Am. Chem. Soc., 1985, 107, 7008-7018.

7. “Glycerol kinase: Synthesis of dihydroxyacetone phosphate, syn-glycerol-3-phosphate, and chiral analogs,” Debbie C. Crans and George M. Whitesides, J. Am. Chem. Soc., 1985, 107, 7019-7027.

8. “Probes of the binding change mechanism and possible rotational catalysis by studies of subunit interactions,” P. D. Boyer, T. Melese, Z. Xue, R. J.Kandpal, Debbie. C. Crans and J. D. Wise, EBEC Reports, 1986, 4, 236.

9. “Enzymatic regeneration of ATP: Acetyl phosphate, phosphoenolpyruvate, methoxycarbonyl phosphate, dihydroxyacetone phosphate, 5-phospho-D-ribosyl-a-1-pyrophosphate, uridine-5′-diphosphoglucose,” Debbie C. Crans, Romas J. Kazlauskas, Bernard L. Hirshbein, Chi-Huey Wong, Obsidiana Abril and George M. Whitesides, Methods Enzymol., 1987, 136, 263-280.

10. “The enantiomeric purity of polar substrates can be determined using chiral lanthanide NMR shift reagents in polar solvents,” Linda M. Sweeting, Debbie C. Crans and George M. Whitesides, J. Org. Chem., 1987, 52, 2273-2276.

11. “Synthesis of 3-deoxy-D-manno-2-octulosonate-8-phosphate (KDO-8-P) from D-arabinose: Generation of D-arabinose-5-phosphate using hexokinase,” Mark D. Bednarski, Debbie C. Crans, Robert DiCosimo, Ethan S. Simon, Philip D. Stein, George M. Whitesides and Marilyn J. Schneider, Tetrahedron Letters, 1988, 29, 427-430.

Publications at Colorado State University (underline indicates undergraduate student co-authors)

12. “Spontaneous and reversible interactions of vanadium(V) oxyanions with amine derivatives,” Debbie C. Crans and Paul K. Shin, Inorg. Chem., 1988, 27, 1797-1806.

13. “Reversible and in situ formation of organic arsenates and vanadates as organic phosphate mimics in enzymatic reactions: Mechanistic investigation of aldol reactions and synthetic applications,” D. G. Drueckhammer, J. R. Durrwachter, R. L. Pederson, Debbie. C. Crans, L. Daniels and C-H. Wong, J. Org. Chem., 1989, 54, 70-77.

14. “Interaction of trace levels of vanadium (IV) and (V) in biological systems,” Debbie C. Crans, Robin L. Bunch and Lisa A. Theisen, J. Am. Chem. Soc., 1989, 111, 7597-7607.

15. “Vanadate monomers and dimers both inhibit the human prostatic acid phosphatase,” Debbie C. Crans, Carmen M. Simone, Asish K. Saha and Robert H. Glew, Biochem. Biophys. Res. Comm., 1989, 165, 246-250.

16. “Vanadate tetramer as inhibiting species in enzyme reactions in vitro and in vivo,” Debbie C. Crans, Ellen M. Willging and Steven K. Butler, J. Am. Chem. Soc., 1990, 112, 427-432.

17. “A kinetic method for determination of free vanadium(IV) and (V) at trace level concentrations,” Debbie C. Crans, Miri Shaia Gottlieb, Jeanne Tawara, Robin L. Bunch and Lisa A. Theisen, , 1990, 180, 53-64.

18. “Time-resolved 51V 2-D NMR for studies of kinetic exchange between vanadate oligomers,” Debbie C. Crans, Christopher D. Rithner and Lisa A. Theisen, J. Am. Chem. Soc., 1990, 112, 2901-2908.

19. “Vanadate dimer and tetramer both inhibit glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroidex,” Debbie C. Crans and Susan M. Schelble, Biochemistry, 1990, 29, 6698-6706.

20. “A cyclic vanadium(V) alkoxide – An analog of the ribonuclease inhibitors,” Debbie C. Crans, Robert A. Felty and Mary M. Miller, J. Am. Chem. Soc., 1991, 113, 265-269.

21. “Structural and kinetic characterization of simple complexes as models for vanadate–protein interactions in aqueous solution,” Debbie C. Crans, Per Magnus Ehde, Paul K. Shin and Lage Pettersson, J. Am. Chem. Soc., 1991, 113, 3728-3736.

22. “Substituent effects of organic vanadate esters in imidazole buffered aqueous solutions,” Debbie C. Crans, Susan M. Schelble and Lisa A. Theisen, J. Org. Chem., 1991, 56, 1266-1274.

23. “Nonreductive interaction of vanadate with an enzyme containing a thiol group in the active site: Glycerol-3-phosphate dehydrogenase,” Debbie C. Crans and Carmen M. Simone, Biochemistry, 1991, 30, 6734-6741.

24. “Inhibition of human seminal fluid and Leishmania donovani phosphatases by molybdate heteropolyanions,” Asish K. Saha, Debbie C. Crans, Michael T. Pope, Carmen M. Simone and Robert H. Glew, J. Biol. Chem., 1991, 266, 3511-3517.

25. “Vanadate interactions with bovine copper, zinc-superoxide dismutase as probed by 51V NMR spectroscopy,” Lisa Wittenkeller, Aida Abraha, Ravichandran Ramasamy, Duarte Mota de Freitas, Lisa A. Theisen and Debbie C. Crans, J. Am. Chem. Soc., 1991, 113, 7872-7881.

26. “NMR, CD and MCD studies of vanadate-nucleosides and vanadate-deoxynucleosides,” Debbie. C. Crans, Sven E. Harnung, Eric Larsen, Paul K. Shin, Lisa A. Theisen and I. Trabjerg, Acta Chem. Scand., 1991, 45, 456-462.

27. “Synthesis and reactivity of oxovanadium(V) trialkoxides of bulky and chiral alcohols,” Debbie C. Crans, Haojiang Chen and Robert A. Felty, J. Am. Chem. Soc., 1992, 114, 4543-4550.

28. “Chemically induced modification of cofactor specificity of glucose-6-phosphate dehydrogenase,” Debbie C. Crans, Carmen M. Simone and John S. Blanchard, J. Am. Chem. Soc., 1992, 114, 4927-4928.

29. “Interaction of rabbit muscle aldolase at high ionic strengths with vanadate and other oxoanions,” Debbie C. Crans, Katakam Sudhakar and Thomas J. Zamborelli, Biochemistry, 1992, 31, 6812-6821.

30. “(-)Cryptaustoline. Its synthesis, revision of absolute stereochemistry, and mechanism of inversion of stereochemistry,” Albert I. Meyers, Thais M. Sielecki, Debbie C. Crans, Robert W. Marshman and Thank Nguyen, J. Am. Chem. Soc., 1992, 114, 8483-8489.

31. “Oxovanadium(V) 1,3-propanediolate chloride complexes – tetrameric clusters,” Debbie C. Crans, Robert W. Marshman, Miri Shaia Gottlieb, Oren P. Anderson and Mary M. Miller, Inorg. Chem., 1992, 31, 4939-4949.

32. “Interaction of porcine uterine fluid purple acid phosphatase with vanadate and vanadyl cation,” Debbie C. Crans, Carmen M. Simone, Richard C. Holz and Lawrence Que, Jr., Biochemistry, 1992, 31, 11731-11739.

33. “Comparison of phosphorus metabolites in various extraction procedures of Phaseolus vulgaris seeds using 31P NMR spectroscopy,” Debbie C. Crans, Milos Mikus and Robert W. Marshman, Anal. Biochem., 1993, 209, 85-94.

34. “Structural characterization and solution properties of a dimeric tetrahedral vanadium(V) chloride alkoxide,” Debbie C. Crans, Robert A. Felty, Oren P. Anderson and Mary M. Miller, Inorg. Chem., 1993, 32, 247-248.

35. “NADV – a new cofactor for alcohol dehydrogenase from Thermo-anaerobium brockii,” Debbie C. Crans, Robert W. Marshman, Rikke Nielsen and Irene Felty, J. Org. Chem., 1993, 58, 2244-2252.

36. “Vanadium(V)-protein model studies: Solid state and solution structure,” Debbie C. Crans, Haojiang Chen, Oren P. Anderson, and M. M. Miller, J. Am. Chem. Soc., 1993, 115, 6769-6776.

37. “Interaction of polyoxovanadates and selected polyoxomolybdates with proteins,” Debbie C. Crans, Molecular Engineering, 1993, 3, 277-284.

38. “Characterization of vanadium(V) complexes in aqueous solutions: Ethanolamine and glycine derived complexes,” Debbie C. Crans and Paul K. Shin, J. Am. Chem. Soc., 1994, 116, 1305-1315.

39. “Oxovanadium(V) alkoxide derivatives of 1,2-diols: Synthesis and solid-state 51V NMR characterization,” Debbie C. Crans, Robert A. Felty, Haojiang Chen, Hellmut Eckert and Nandini Das, Inorg. Chem., 1994, 33, 2427-2438.

40. “The X-ray structure of (NH4)6(Gly-Gly)2V10O28•4H2O: Model studies of polyoxometalate-protein interactions,” Debbie. C. Crans, M. Mahroof-Tahir, O. P. Anderson and S. M. Miller, Inorg. Chem., 1994, 44, 5586-5590.

41. “Phytate metabolism in bean seedlings during post-germinative growth,” Debbie C. Crans, Milos Mikus and Blayne R. Friehauf, J. Plant Physiol., 1995, 145, 101-107.

42. “A slow exchanging vanadium(V) peptide complex: Vanadium(V)-Gly-Tyr,” Debbie C. Crans, Hartmut Holst, Anastasios Keramidas and Dieter Rehder, Inorg. Chem., 1995, 34, 2524-2534.

43. “Structure of the dimeric ethylene glycol- vanadate complex and other 1,2-diol-vanadate complexes in aqueous solution. Vanadate-based transition state analog complexes of phosphotransferases,” William J. Ray, Jr., Debbie. C. Crans, J. Zheng, James W. Burgner, II, H. Deng, and Mohammed Mahroof-Tahir, J. Am. Chem. Soc., 1995, 117, 6015-6026.

44. “Comparison of phytate in radicle, plumula, scutellum and endosperm of Zea mays and Zea diploperennis,” Milos Mikus, Alexander Lux, Debbie C. Crans, Paul K. Shin and Josef Kristin, Structure and Function of Roots, Proceedings of the 4th International Symposium on Structure and Function of Roots, Baluska, F.; Cianporova, M.; Gaspariakova; Barlow, O. (Eds.) Kluwer Academic Publishers, 1995, 175-180.

45. “The effect of vanadate on growth and phospholipid levels in the root and hypocotyl of bean seedlings (Phaseolus vulgaris L.),” Milos Mikus, Paul K. Shin and Debbie C. Crans, Structure and Function of Roots, Proceedings of the 4th International Symposium on Structure and Function of Roots, Baluska, F.; Cianporova, M.; Gaspariakova; Barlow, O. (Eds.) Kluwer Academic Publishers, 1995, 181-187.

46. “Application of NMR spectroscopy to studies of aqueous coordination chemistry of vanadium(V) complexes,” Debbie C. Crans, Paul K. Shin and Kathleen Armstrong, Mechanistic Bioinorganic Chemistry, Thorp, H. H.; Pecoraro, V. L. (Eds.) ACS Symposium Series, 1995, 246, 303-328.

47. “Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents,” Debbie C. Crans, Mohammed Mahroof-Tahir and Anastasios D. Keramidas, Cell Mol. Biochemistry, 1995, 17-24.

48. “Organic vanadium compounds – Transition state analogy with organic phosphorus compounds,” Debbie C. Crans, Anastasios D. Keramidas and Chryssoula Drouza, Phosphorus, Sulphur, and Silicon, 1996, 109-110, 245-248.

49. “Factors affecting solution properties of vanadium(V) compounds: X-ray structure of b-cis-NH4[VO2(EDDA)],” Debbie C. Crans, Anastasios D. Keramidas, Mohammad Mahroof-Tahir, Oren P. Anderson, and Susie M. Miller, Inorg. Chem., 1996, 35, 34599-34606.

50. “Evidence for distinct vanadyl(+4)-dependent activating system for manifesting insulin-like effects,” Jinping Li, Gerard Elberg, Debbie C. Crans, and Yoram Shechter, Biochemistry, 1996, 35, 8314-8318.

51. “Four- and five-coordinate oxovanadium(V) alkoxides: Do steric effects or electronic properties dictate the geometry?,” Jean Yves Kempf, Bernard Maigret and Debbie C. Crans, Inorg. Chem., 1996, 35, 6485-6494.

52. “Protein bodies in dry germ of cereals,” Alexander Lux, Zora Hanácková, Jozef Kristín, Debbie C. Crans and Milos Mikus, Acta Universitatis Carolinae Biologica, 1997, 41, 111-119.

53. “Vanadium oxoanions and cAMP-dependent protein kinase: An anti-substrate inhibitor,” Scott Pluskey, Mohammad Mahroof-Tahir, Debbie C. Crans and David S. Lawrence, Biochem. J., 1997, 321, 333-339.

54. “Insulin-mimetic action of vanadium compounds on osteoblast-like cells in culture,” S. B. Etcheverry, Debbie. C. Crans, A. D. Keramidas and A. M. Cortizo, Arch. Biochem. Biophys., 1997, 338, 7-14.

55. “Syntheses, X-Ray structures and solution properties of [V4O4{(OCH2)3CCH3}3(OC2H5)3] and [V4O4{(OCH2)3CCH3}2(OCH3)6]: Examples of new ligand coordination modes,” Debbie C. Crans, Feilong Jiang, John Chen, Oren P. Anderson and Mary M. Miller, Inorg. Chem., 1997, 36, 1038-1047.

56. “Solution and solid state properties of [N-(2-Hydroxylethyl)Iminodiacetate] Vanadium(IV), -(V) and -(IV/V) complexes,” Mohammed Mahroof-Tahir, Anastasios D. Keramidas, Ron B. Goldfarb, Oren P. Anderson, Mary M. Miller and Debbie C. Crans, Inorg. Chem., 1997, 36, 1657-1668.

57. “Six-coordinated vanadium(IV) and (V) complexes of benzimidazole and pyridyl containing ligands,” Debbie C. Crans, Anastasios D. Keramidas, Shahid S. Amin, Oren P. Anderson and Susie M. Miller, J. Chem. Soc., Dalton Transactions, 1997, 2799-2812. (See also erratum 1997, 4461)

58. “Synthesis, structure and biological activity of a new insulinomimetic peroxovanadium compound: Bisperoxovanadium imidazole monoanion,” Debbie C. Crans, Anastasios D. Keramidas, Helana Hoover-Litty, Oren P. Anderson, Mary M. Miller, Lynn M. Lemoine, Susan Pleasic-Williams, Mark Vandenberg, Anthony J. Rossomando and Laurel Sweet, J. Am. Chem. Soc., 1997, 119, 5447-5448. (erratum, 1997, 4461)

59. “Speciation in vanadium bioinorganic systems. 4. Interactions between vanadate, adenosine, and imidazole – an aqueous potentiometric and 51V NMR study,” Katarina Elvingston, Debbie C. Crans and Lage Pettersson, J. Am. Chem. Soc., 1997, 119, 7005-7012.

60. “Vanadium(V) hydroxylamido complexes: Solid state and solution properties,” Anastasios D. Keramidas, Susie M. Miller, Oren P. Anderson and Debbie C. Crans, J. Am. Chem. Soc., 1997, 119, 8901-8915.

61. “Chemistry of relevance to vanadium in the environment,” Debbie C. Crans, Shahid Amin and Anastasios D. Keramidas, Vanadium in the Environment, Part I, J. Nriagu, Ed.; John Wiley & Sons, Inc.: New York, 1998, 30, 73-96.

62. “Metal-carbohydrate complexes in solution,” Jean-Franqois Verchere, Stella Chapelle, Feibo Xin and Debbie C. Crans, Prog. Inorg. Chem., 1998, 47, 837-945.

63. “The chemistry of vanadium in aqueous and nonaqueous solution chemistry,” Debbie C. Crans, Alan S. Tracey (Eds.), In ACS Symposium Series, Debbie Crans and A. S. Tracey, Eds.; (from the 1997 Fifth Chemical Congress of North America Conference Proceedings Cancun, Mexico); ACS Symposium Ser., 1998. 711, 2-29.

64. “Peroxo-, hydroxylamido- and acac-derived vanadium complexes,” Debbie C. Crans, Alan S. Tracey, In ACS Symposium Series, D. Crans and A. S. Tracey, Eds.; (from the 1997 Fifth Chemical Congress of North America Conference Proceedings Cancun, Mexico); ACS Symposium Ser., 1998, 711, 82-103.

65. “Insulin-like effects of vanadium; Reviewing in vivo and in vitro studies and mechanisms of action,” Yoram Shechter, Gerard Elberg, Assia Shisheva, Dov Gefel, Natesampillai Sekar, Sun Qian, Rafi Bruck, Eythan Gershonov, Debbie C. Crans, Y. Toldwasser, Mati Fridkin and Jinping Li, In ACS Symposium Series, Debbie. C. Crans and A. S. Tracey, Eds.; (from the 1997 Fifth Chemical Congress of North America Conference Proceedings Cancun, Mexico); ACS Symposium Ser., 1998, 711, 308-315.

66. “Vanadium(V) complexes of polydentate Aminoalcohols: Fine-tuning complex properties,” Debbie C. Crans and Iman Boukhobza, J. Am. Chem. Soc., 1998, 120, 8069-8078.

67. “Stepwise cluster assembly using VO2(acac) as a precursor: cis-[VO(OCH(CH3)2)(acac)2], [V2O2(-OCH3)2(acac)2(OCH3)2], [V3O3{,-(OCH2)3CCH3}2(acac)2(OC2H5)], [V4O4(-O)2(-OCH3)2(3-OCH3)2(acac)2(OCH3)2]•2CH3CN,” Feilong Jiang, Oren P. Anderson, Susie M. Miller, John Chen, Mohammad Mahroof-Tahir and Debbie C. Crans, Inorg. Chem., 1998, 37, 5439-5451.

68. “Speciation in vanadium bioinorganic systems. 5. Interactions between vanadate, uridine and imidazole – an aqueous potentiometric, 51V and 17O NMR Study,” Katarine Elvingston, Anastasios D. Keramidas, Debbie C. Crans, and Lage Pettersson, Inorg. Chem., 1998, 37, 6163-6160.

69. “Dinuclear oxovanadium(IV) (phosphonomethyl)lminodiacetate complexes: Na4[V2O2{(O)2P(O)-CH2N(CH2COO)2}2]10H2O and Na8[V2O2{(O)2P(O)Ch2N(CH2COO)2}2]216H2O,” Debbie C. Crans, Feilong Jiang, Oren P. Anderson and Susie M. Miller, Inorg. Chem., 1998, 37, 6645-6655.

70. “Effects of vanadium complexes with organic ligands on glucose metabolism: A comparison study in diabetic rats,” B. A. Reul, S. S. Amin, J. P. Buchet, L. N. Ongemba, Debbie. C. Crans and S. M. Brichard, British J. Pharm., 1999, 126, 467-477.

71. “Solution characterization of vanadium(V) and (IV) N-(phosphonomethyl)iminodiacetate complexes: Direct observation of one enantiomer converting to the other in an equilibrium mixture,” Debbie C. Crans, Feilong Jiang, Iman Boukhobza, Istvan Bodi and Tamas Kiss, Inorg. Chem., 1999, 38, 3275-3282.

72. “Chemistry and insulin mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives,” Sean S. Amin, Kirk Cryer, Boyan Zhang, Sandra S. Eaton, Oren P. Anderson, Susie M. Miller, Benedicte A. Reul, Sonia M. Brichard and Debbie C. Crans, Inorg. Chem., 2000, 39, 406-416.

73. “Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds,” Debbie C. Crans, J. Inorg. Biochem., 2000, 80, 123-131.

74. “Aqueous chemistry of ammonium dipicolinatooxovanadium(V): The first organic vanadium(V) insulin-mimetic compound,” Debbie C. Crans, Luqin Yang, Tamas Jakusch and Tamas Kiss, Inorg. Chem., 2000, 39, 4409-4416.

75. “Methylation of neutral pseudotetrahedral zinc thiolate complexes: Model reactions for alkyl group transfer to sulfur by Zn-containing enzymes,” Chris R. Warthen, Brain S. Hammes, Carl J. Carrano and Debbie C. Crans, J. Biol. Inorg. Chem., 2001, 6, 82-90.

76. “Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV),” G. R. Willsky, A. B. Goldfine, P. J. Kostyniak, J. H. McNeill, L. Yang, A. R. Khan and Debbie. C. Crans, J. Inorg. Biochem., 2001, 85, 33-42.

77. “Bis(acetylamido)oxovanadium(IV) complexes: Solid state and solution studies,” Debbie C. Crans, A. Raza Khan, Mohammad Mahroof-Tahir, Sujit Mondal, Susie M. Miller, Agnete la Cour, Oren P. Anderson, Tamas Jakusch and Tamas Kiss, Dalton Transactions, 2001, 3337-3345.

78. “Cobalt(II) and cobalt(III) dipicolinate complexes: Solid state, solution and in vivo insulin-like properties,” Luqin Yang, Debbie C. Crans, Susie M. Miller, Agnete la Cour, Oren P. Anderson, Peter M. Kaszynski, Michael E. Godzala, III, LaTanya D. Austin and Gail R. Willsky, Inorg. Chem., 2002, 41, 4859-4871.

79. “Rational synthesis and X-ray structures of [MnII4(H2O)2(AsVW9O34)2]10- from [AsIII4W40O140]28-, MnO4- and Mn++,” Cristina Rosu, Debbie C. Crans and Timothy J. R. Weakley, Polyhedron, 2002, 21, 259-262.

80. “4-hydroxypyridine-2,6-dicarboxylatooxovanadium(V) complexes: Solid state and aqueous chemistry,” Luqin Yang, Agnete la Cour, Oren P. Anderson and Debbie C. Crans, Inorg. Chem., 2002, 41, 6322-6331.

81. “Inelastic neutron scattering on three mixed-valence dodecanuclear polyoxovanadate clusters,” Reto Basler, Gregory Chaboussant, Andreas Sieber, Hansperter Andres, Mark Murie, Paul Kögerler, Hartmut Bögge, Debbie C. Crans, Erich Krickemeyer, Stefan Janssen, Hannu Mutka, Achim Müller and Hans-Ulrich Güdel, Inorg. Chem., 2002, 41, 5675-5685.

82. “Speciation of transition metal ion complexes in alkaline solutions of alditols. 1. Cu(II) complex formation with D-mannitol,” E. Norkus, J. Vaiciuniene, J. Reklaitis, E. Gaidamauskas and Debbie C. Crans, Chemija (Vilnius), 2002, 13, N 3, 119-128.

83. “Speciation of transition metal ion complexes in alkaline solutions of alditols. 2. Cu(II) complex formation with D-sorbitol,” E. Norkus, J. Vaiciuniene, J. Reklaitis and Debbie C. Crans, Chemija (Vilnius), 2002, 13, N 3, 129-137.

84. “Transition and heavy metal ions complex formation with 2,5-pyridinedicarboxylic acid,” E. Norkus, I. Stalnioniene and Debbie C. Crans, Chemine technologija (Kaunas), 2002, N 4(25), 9-12.

85. “Cu(II), Pb(II) and Cd(II) complex formation with pyridine-2,6-dicarboxylate and 4-hydroxypyridine-2,6-dicarboxylate in aqueous solutions,” E. Norkus, I. Stalnioniene and Debbie C. Crans, Chemija (Vilnius), 2002, 13, N 4, 194-202.

86. “(4-hydroxypyridine-2,6-dicarboxylate) oxovanadate(V) – a new insulin-like compound: chemistry, effects on myoblast and yeast cell growth and effects on hyperglycemia in rats with STZ-induced diabetes,” Debbie C. Crans, Luqin Yang, Josephine A. Alfano, Lai-Har Chi, Wenzheng Jin, Mohammad Mahroof-Tahir, Karen Robbins, Masoud M. Toloue, Leong K. Chan, Andrew J. Plante, Rebecca Z. Grayson and Gail R. Willsky, Coord. Chem. Rev., 2003, 237, 13-22.

87. “Interaction of pyridine- and 4-hydroxypyridine-2,6-dicarboxylic acids with heavy metal ions in aqueous solutions,” Eugenijus Norkus, Irena Stalnioniene and Debbie C. Crans, Heteroatom Chemistry, 2003, 14(7), 625-632.

88. “The membrane transport of vanadium compounds and the interaction with the erythrocyte membrane,” Xiaogai Yang, Kui Wang, Jingfen Lu and Debbie C. Crans, Coord. Chem. Rev., 2003, 237(1-2), 103-111.

89. “Applications of paramagnetic NMR spectroscopy for monitoring transition metal complex stoichiometry and speciation,” Debbie C. Crans, Luqin Yang, Ernestas Gaidamauskas, A. Raza Khan, Wenzheng Jin and Ursula Simonis, ACS Symposium Series, 2003, 858, 304-332.

90. “Vanadium(IV/V) speciation of pyridine-2,6-dicarboxylic acid and 4-hydroxy-pyridine-2,6-dicarboxylic acid complexes: Potentiometry, EPR spectroscopy and comparison across oxidation states,” Tamas Jakusch, Wenzheng Jin, Luqin Yang, Tamas Kiss, Debbie C. Crans, J. Inorg. Biochem., 2003, 95(1), 1-13.

91. “Vanadium(IV) and vanadium(V) complexes of dipicolinic acid and derivatives: Synthesis, X-ray structure, solution state properties and effects in rats with STZ-induced diabetes,” Debbie C. Crans, Mohammad Mahroof-Tahir, Michael D. Johnson, Patricia C. Wilkins, Luqin Yang, Karen Robbins, Alison Johnson, Josephine A. Alfano, Michael E. Godzala, III, La Tanya Austin and Gail R. Willsky, Inorg. Chem. Acta., 2003, 356C, 365-378.

92. “The permeability and cytotoxicity of insulin-mimetic vanadium compounds,” Xiao-Gai Yang, Xiao-Da Yang, Lan Yuan, Kui Wang and Debbie C. Crans, Pharmaceutical Research, 2004, 21(6), 1026-1033.

93. “The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds,” Debbie C. Crans, Jason J. Smee, Ernestas Gaidamauskas and Luqin Yang, Chem. Rev., 2004, 104(2), 849-902.

94. “Inhibition of yeast growth by molybdenum-hydroxylamido complexes correlates with their presence in media at differing pH values”, Debbie C. Crans, Jason J. Smee, Edita G. Gaidamauskiene, Oren P. Anderson, Susie M. Miller, Wenzheng Jin, Ernestas Gaidamauskas, Etienne Crubellier, Rose Grainda, Lar-Har Chi and Gail R. Willsky, J. Inorg. Biochem., 2004, 98, 1837-1850.

95. “Interaction of pyridine-2,5-dicarboxylic acid with heavy metal ions in aqueous solutions,” Eugenijus Norkus, Ernestas Gaidamauskas, Irena Stalnioniene and Debbie C. Crans, Heteroatom Chem., 2005, 16(4), 285-291.

96. “Interaction of dipicolinatodioxovanadium(V) with polyatomic cations and surfaces in reverse micelles,” Jessica Stover, Christopher D. Rithner, Rae Ann Inafuku, Debbie C. Crans and Nancy E. Levinger, Langmuir, 2005, 21, 6250-6258.

97. “Evidence of two-step deprotonation of mannitol in aqueous solution,” Ernestas Gaidamauskas, Eugenijus Norkus, Jurate Vaiciuniene, Debbie C. Crans, Tapani Vuorinen, Jane Jaciauskiene and Gintaras Baltrunas, Carbohydrate Res., 2005, 340, 1553-1556.

98. “Aqueous chemistry of the vanadiumIII and the VIII-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats,” Péter Buglyó, Debbie C. Crans, Eszter M. Nagy, Ruby Lisa Lindo, Luqin Yang, Jason J. Smee, Lai-Har Chi, Michael E. Godzala III and Gail R. Willsky, Inorg. Chem., 2005, 44, 5416-5427.

99. “Fifteen year of dancing with Vanadium,” Debbie C. Crans, Pure Appl. Chem., 2005, 77, 9, 1497-1527.

100. “Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties: Chromium agents,” M.D. Cohen, M. Sisco, C. Prophete, L. Chen, J.T. Zelikoff, J.J. Smee, A.A. Holder and Debbie C. Crans, J. of Immunotox., 2006, 3, 69-81.

101. “Reduction of vanadium(V) by L-ascorbic acid at low and neutral pH: Kinetic, mechanistic and spectroscopic characterization,” Patricia C. Wilkins, Michael D. Johnson, Alvin A. Holder and Debbie C. Crans, Inorg. Chem., 2006, 45, 1471-1479.

102. “Transition state analogues for nucleotidyl transfer reactions: Structure and stability of pentavalent vanadate and phosphate ester dianions,” James Borden, Debbie C. Crans and Jan Florian, J. Phys. Chem. B, 2006, 110, 14988-14999.

103. “Molecule probe location in reverse micelles determined by NMR dipolar interactions,” Debbie C. Crans, Christopher D. Rithner, Bharat Baruah, Bridget L. Gourley and Nancy E. Levinger, J. Am. Chem. Soc., 2006, 128, 4437-4445.

104. “Spectrometric and electrochemical investigations of vanadium(V) and vanadium(IV) tartrate complexes in solution,” Ahmad R. Khan, Debbie C. Crans, Rasa Pauliukate and Eugene Norkus, J. Brazil. Chem. Soc., 2006, 17, 895-904.

105. “Self-exchange electron transfer in high oxidation state non-oxo metal complexes: Amavadin,” Jeremy Lenhardt, Bharat Baruah, Debbie C. Crans and Michael D. Johnson, Chem. Comm., 2006, 4641-4643.

106. “When water is not water? Exploring water confined in large reverse micelles using a highly charged inorganic molecular probe,” Bharat Baruah, Jennifer M. Roden, Myles Sedgwick, N. Mariano Correa, Debbie C. Crans and Nancy E. Levinger, J. Am. Chem. Soc., 2006, 128, 12758-12765.

107. “The permeability and cytotoxicity of insulin-mimetic vanadium (III,IV,V)-dipicolinate complexes,” Y. Zhang, X.D. Yang, K. Wang and Debbie C. Crans, J. Inorg. Biochem., 100 (1), 2006, 80-87.

108. “Oxovanadates: A novel probe for studying lipid-water interfaces,” Debbie C Crans, Bharat Baruah and Nancy E Levinger, Biomedicine & Pharmacotherapy, 2006, 60(4), 174-181.

109. “Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate,” GR Willsky, LH Chi, Y Liang, DP Gaile, Z Hu, Debbie C. Crans, Physiological Genomics, 2006, 26(3), 192-201.

110. “Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties: Vanadium agents,” M.D. Cohen, C. Prophete, M. Sisco, L. Chen, J.T. Zelikoff, J.J. Smee, A.A. Holder, A.J. Ghio, J.D. Stonehuerner and Debbie C. Crans, J. Immunotox. 2007, 4(1), 49-60.

111. “Simple oxovanadates as multiparameter probes of reverse micelles,” Bharat Baruah, Debbie C. Crans and Nancy E. Levinger, Langmuir, 2007, 23, 6510-6518.

112. “Electron spin lattice relaxation of V(IV) complexes in glassy solutions between 15 and 70 K,” Alistair J. Fielding, Dong Bin Back, Michael Engler, Bharat Baruah, Debbie C. Crans, Gareth R. Eaton and Sandra S. Eaton, ACS Symposium Series, 2007, 974, 364-375.

113. “Do vanadium compounds drive reorganization of the plasma membrane and activation of insulin receptors with lipid rafts,” Deborah A. Roess, Steven M. L. Smith, Alvin A. Holder, Bharat Baruah, Alejandro M. Trujillo, Daniel Gilsdorf, Michelle L. Stahla, and Debbie C. Crans, ACS Symposium Series, 2007, 974, 121-134.

114. “Comparing administration route in rats with streptozocin-induced diabetes and inhibition of myoblast growth of vanadium [V(III), V(IV) and V(V)] dipicolinic acid complexes,” Gail R. Willsky, Michael E. Godzalla III, Paul J. Kostyniak, Lai-Har Chi, Rohit Gupta, Violet G. Yuen, John H. McNeill, Mohammad Mahroof-Tahir, Jason J. Smee, Luqin Yang, Aaron Kobernick, Shari Watson, and Debbie C. Crans, ACS Symposium Series, 2007, 974, 93-109.

115. “Chelation of vanadium(V) by difluoromethylene bisphosphonate, a structural analog of pyrophosphate,” Debbie C. Crans, Alvin A. Holder, Tapan Kumar Saha, G. K. Surya Prakash, Muhammed Yousufuddin, Roman Kultyshev, Rehana Ismail, Myron F. Goodman, James Borden and Jan Florian, Inorg. Chem., 2007, 46, 6723-6732.

116. “Investigating the vanadium environments in hydroxylamido V(V) dipicolinate complexes using 51V NMR spectroscopy and density functional theory,” Kristopher J. Ooms, Stephanie E. Bolte, Jason Smee, Bharat Baruah, Debbie C. Crans and Tatyana Polenova, Inorg. Chem., 2007, 46, 9285-9293.

117. “4-amino and 4-nitrodipicolinatovanadium(V) complexes and their hydroxylamido derivatives: Synthesis, aqueous and solid state properties,” Jason J. Smee, Jason A. Epps, Guillaume Teissedre, Mandy Maes, Nichola Harding, Luqin Yang, Bharat Baruah, Susie M. Miller, Oren P. Anderson, Gail R. Willsky and Debbie C. Crans, Inorg. Chem., 2007 46, 9827-9840.

118. “Anti-diabetic effects of cesium aqua (N,N’ethylene(salicylideneimiato)-5-sulfonato) oxovanadium(IV) dihydrate in streptozotocin – induced diabetic rats,” Ming Li, D. Wei, Weijin Ding, Bhatat Baruah and Debbie C. Crans, Biol. Trace Element Res., 2008, 121, 226-232.

119. “Impairment of ascorbates’ anti-oxidant properties in confined media: Inter and intramolecular reactions with air and with vanadate at acidic pH,” Debbie C. Crans, Bharat Baruah, Ernestas Gaidamauskas, Brant G. Lemons and Michael D. Johnson, J. Inorg. Biochem, 2008, 102, 1334-1347.

120. “Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds,” Manuel Aureliano, v Rui O. Duarte, J.J.G. Moura and Debbie C. Crans, Inorg. Chem., 2008, 47, 5677-5684.

121. “Effects of vanadium-containing compounds on membrane lipids and on microdomains used in receptor-mediated signaling,” Deborah A. Roess, Steven M. L. Smith, Peter Winter, Jun Zhou, Ping Dou, Bharat Baruah, Alejandro M. Trujillo, Nancy E. Levinger, Xioda Yang, B. George Barisas and Debbie C. Crans, Chemistry & Diversity, 2008, 5, 1558-1570.

122. “1H NMR studies of aerosol-OT reverse micelles with alkali and magnesium counterions: preparation and analysis of MAOTs,” Michelle L. Stahla, Bharat Baruah, Dustin M. James, Michael D. Johnson, Nancy E. Levinger and Debbie C. Crans, Langmuir, 2008, 24, 6027-6035.

123. “Do probe molecules influence water in confinement?,” Bharat Baruah, Laura A. Swafford, Debbie C. Crans and Nancy E. Levinger, J. Phys. Chem. B, 2008, 112, 10158-10164.

124. “51V NMR and density functional theory studies of vanadium environments in V(V)O2 dipicolinic acid complexes,” Stephanie E. Bolte, Kristopher J. Ooms, Tatyana Polenova, Bharat Baruah, Debbie C. Crans and Jason J. Smee, J. Chem. Phys., 2008, 128, 052317/1-052317/11.

125. “Metal complexation chemistry used for phosphate and nucleotide determination: An investigation of the Yb3+-pyrocatechol violet sensor,” Ernestas Gaidamauskas, Kanokkarn Saejueng, Alvin A. Holder, Subalita Baruah, Boris A. Kashemirov, Debbie C. Crans and Charles E. McKenna, J. Biol. Inorg. Chem, 2008, 13, 1291-1299.

126. “Penetration of negatively charged lipid interfaces by the doubly deprotonated dipicolinate,” Debbie C. Crans, Alejandro M. Trujillo, Sandra Bonetti, Christopher D. Rithner, Bharat Baruah and Nancy E. Levinger, J. Org. Chem., 2008, 73, 9633-9640.

127. “Inhibition of protein tyrosine phosphatase 1B and alkaline phosphatase by bis(maltolato)oxovanadium (IV),” M. Li, W. Ding, B. Baruah, Debbie C Crans and R. Wang, J. Inorg. Biochem., 2008, 102, 1846-1853. (This paper was highlighted by F1000)

128. “Deprotonation of -cyclodextrin in alkaline solutions,” Ernestas Gaidamauskas, Eugenijus Norkus, Eugenijus Butkus, Debbie C. Crans and Giedre Grinciene, Carbohydrate Res., 2009 344, 250-254.

129. “Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats,” Ming Li, Jason J. Smee, Wenjun Ding and Debbie C. Crans, J. Inorg. Biochem., 2009, 103, 585-589.

130. “Decavanadate (V10O286-) and oxovanadates: Oxometalates with many biological activities” Manuel Aureliano and Debbie C. Crans, J. Inorg. Biochem., 2009, 103, 536-546.

131. “Chloro-substituted dipicolinate vanadium complexes: Synthesis, solution, solid-state and insulin enhancing properties,” Jason J. Smee, Jason A. Epps, Kristopher Ooms, Stephanie Bolte, Tatyana Polenova, Bharat Baruah, Luqin Yang, Wenjun Ding, Ming Li, Gail R. Willsky, Agnete la Cour, Oren P. Anderson and Debbie C. Crans, J. Inorg. Biochem., 2009, 103, 575-584.

132. “Anti-diabetic effects of vanadium (III, IV, V) – chlorodipicolinate complexes in streptozotocin-induced diabetic rats,” Ming Li, Wenjun Ding, Jason J. Smee, Bharat Baruah, Gail R. Willsky and Debbie C. Crans, BioMetals, 2009, 103, 585-905.

133. “Electron transfer in non-Oxo vanadium(IV) and (V) complexes: Kinetic studies of an amavadin model” Jeremy M. Lenhardt, Bharat Baruah, Debbie C. Crans and Michael D. Johnson, Pure Appl. Chem., 2009, 81, 1241-1249.

134. “Impact of confinement and interfaces on coordination chemistry: Probing oxovanadate reactions including proton transfer reactions in reverse micelles,” Debbie C. Crans, Bharat Baruah, Allison Ross and Nancy E. Levinger, Coord. Chem. Rev., 2009, 253, 2178-2185.

135. “What’s inside a nonionic reverse micelle? Probing the interior of Igepal reverse micelles using decavanadate,” Myles A. Sedgwick, Debbie C. Crans and Nancy E. Levinger, Langmuir, 2009, 25, 5496-5503.

136. “51V solid-state NMR and density functional theory studies of eight-coordinate non-oxo vanadium complexes: Oxidized amavadin,” Kristopher J. Ooms, Stephanie E. Bolte, Bharat Baruah, M. A. Choudhary, Debbie C. Crans and Tatyana Polenova, Dalton Transactions, 2009, 3262-3269 (DOI: 10.1039/b820383k).

137. “Complexation of bisphosphonates with Ytterbium(III): Application of phosphate and ATP detection assay based on Yb3+-pyrocatechol violet,” Ernestas Gaidamauskas, Helen Parker, Boris A. Kashemirov, Alvin A. Holder, Kanokkarn Saejueng, Charles E. McKenna and Debbie C. Crans, J. Inorg. Biochem., 2009, 103, 1652-1657 (DOI:10.1016/j.jinorgbio.2009.09.006).

138. “Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes,” Maria Joao Pereira, Eugenia Carvalho, Jan W. Eriksson, Debbie C. Crans and Manuel Aureliano, J. Inorg. Biochem., 2009, 103, 1687-1692.